AdvaMed, the Medtech Association, announced the establishment of a new Medical Imaging Technology division focused on advocating on behalf of large and small companies for the essential role of medical imaging technology, radiopharmaceuticals, contrast media, and focused ultrasound devices in our nation’s health care system.

Medical imaging companies such as Bayer, Fujifilm Sonosite, GE HealthCare, Hologic, Philips, and Siemens Healthineers have formally established AdvaMed as the new home for advocacy on behalf of medical imaging companies, which previously sat within the Medical Imaging & Technology Alliance (MITA), a division of the National Electrical Manufacturers Association (NEMA).

“This new division is a big step forward not merely for the medical imaging sector, but for AdvaMed and the entire medtech industry. Never before have medical technologies been so connected and interdependent as they are today—and it’s really only the beginning,” said Scott Whitaker, AdvaMed president and CEO. “No trade organization is better prepared than AdvaMed to represent the entire medtech industry and take on these advocacy challenges so that our members can continue focusing on what they do best—meeting the needs of the patients they serve.”

Patrick Hope has served as executive director of MITA since 2015 and will now serve as executive director of the new Medical Imaging Technology division at AdvaMed.

“The future is brighter than ever for the medical imaging companies we served at MITA. Our new home at AdvaMed makes perfect sense,” said Hope. “For the first time, we will be surrounded by a team, infrastructure, and resources focused entirely on the patients our companies serve. We will be surrounded by and working directly with experts in medtech policy at the state, national, and global levels.”

This division’s creation comes on the heels of AdvaMed’s announcement last month that it had established a Digital Health division. The recent creation of these two divisions “further demonstrates that AdvaMed is well positioned to lead the entire medtech industry on the advocacy front,” said Whitaker.

In January, AdvaMed will unveil a refreshed version of its “Medical Innovation Agenda for the 118th Congress,” a list of policy and legislative priorities critical to patient care that will include a new set of priorities for the medical imaging sector.